In agreement with our observations from subjects with established T1D, GAD specific T cells in at-risk subjects had more robust functional responses than IA2 specific T cells, including significantly higher proportions of interferon-γ and a significantly lower proportion of cytokine negative T cells. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.